Cardiology

MACE risk similar for white men, women, minorities after PCI

(HealthDay)—Women and minorities undergoing percutaneous coronary intervention (PCI) with everolimus-eluting stents have a risk of major adverse cardiac events (MACE) that is similar to that of white men, according to a ...

Cardiology

Thrombosis odds up with bioresorbable vascular scaffolds

(HealthDay)—Everolimus-eluting bioresorbable vascular scaffolds (BVSs) are associated with increased odds of scaffold thrombosis and other thrombotic events compared with everolimus-eluting metallic stents (EESs), according ...

Cardiology

Treatment of heart attack patients depends on history of cancer

Treatment of heart attack patients depends on their history of cancer, according to research published today in European Heart Journal: Acute Cardiovascular Care. The study in more than 35 000 heart attack patients found ...

Health

More research needed for vitamin D's cardiac effect in PCI

(HealthDay)—More research is needed to assess the role of vitamin D in the prevention of periprocedural myocardial injury, according to a study published online Aug. 25 in the Journal of Clinical Pharmacology.

Cardiology

High platelet reactivity tied to ischemic, bleeding outcomes

(HealthDay)—There is a strong relationship between high on-clopidogrel platelet reactivity and two-year ischemic and bleeding outcomes after drug-eluting stent implantation, according to a study published online Aug. 2 ...

page 15 from 40